Join our Newsletter: https://bit.ly/diabetechnews
Follow me here: https://www.instagram.com/diabe_tech/ https://www.tiktok.com/@diabe_tech https://www.facebook.com/diabetechjustin https://discord.gg/merpqrakz2
I sat down the Founder of Qvin to explore a groundbreaking device that uses menstrual blood to monitor biomarkers for conditions like cervical cancer, fertility, thyroid health, STIs, and more. Already making waves, Qvin’s FDA-cleared test for A1C measures average blood glucose over three months using a pad-like device during a menstrual cycle, with results sent to a smartphone app. We dive into how this innovation is transforming early diagnostics, its current use for cervical cancer screening in Southeast Asia, and Dr. Naser’s journey—from developing a molecule to block skin cancer to simulating cycles with a robot named Betty.
Check out Qvin: https://shop.qvin.com/diabetech
Listen to this podcast: https://www.diabetechpodcast.com/e/qvin-a1c-test/?token=8939a9880a3ed6098f122de3043bc559
More on Patreon: https://bit.ly/3TKpdRK
Products I recommend:
SugarPixel (behind me): https://bit.ly/SugarPixel
Supplies I Recommend: https://amzn.to/3N2Qs5F
DISCLAIMERS: This podcast is not medical advice and is for educational purposes only. Always consult with a physician before making changes to your health care.
______________________________________________
Chapters
00:00 Story Behind Qvin
10:39 State of Women’s Healthcare
14:52 Development of Q-Pad
22:28 Potential Biomarker Testing
26:30 Q-Pad Explained
40:49 Q-Pad Data
42:59 The Future of Biometrics
-- Product Link Disclosure -- In order to create free content, I use affiliate links. This means if you make purchases through certain links, I may earn a small commission (at no extra cost to you).
#diabetes #Qvin #A1C